Table 5.
Correlations between mRNF180 and clinicopathological characteristics of the GC group.
| Clinicopathological characteristics | mRNF180 | |||||
|---|---|---|---|---|---|---|
| N | Positive | Negative | P | Mean ΔCt value | P | |
| Sex | 1.000 | 0.746 | ||||
| Male | 44 | 31 | 13 | 8.22 | ||
| Female | 16 | 12 | 4 | 7.88 | ||
| Age (years) | 0.171 | 0.010 | ||||
| <70 | 34 | 22 | 12 | 9.15 | ||
| ≥70 | 26 | 21 | 5 | 6.80 | ||
| Tumor location | ||||||
| Upper third | 16 | 11 | 5 | NA | ||
| Middle third | 20 | 14 | 6 | NA | ||
| Lower third | 18 | 12 | 6 | NA | ||
| >2/3 stomach | 4 | 4 | 0 | NA | ||
| NA | 2 | |||||
| Tumor size (cm) | 0.142 | 0.033 | ||||
| <6.0 | 25 | 16 | 9 | 9.09 | ||
| ≥6.0 | 32 | 26 | 6 | 7.08 | ||
| NA | 3 | 1 | 2 | |||
| T stage | 0.005 | 0.004 | ||||
| Tis+T1+T2+T3 | 20 | 10 | 10 | 9.78 | ||
| T4 | 34 | 29 | 5 | 6.94 | ||
| NA | 6 | 4 | 2 | |||
| N stage | 0.001 | ≦0.001 | ||||
| N0+N1 | 23 | 11 | 12 | 10.28 | ||
| N2+N3 | 30 | 27 | 3 | 6.27 | ||
| NA | 7 | 5 | 2 | |||
| M stage | 0.463 | 0.011 | ||||
| M0 | 38 | 26 | 12 | 9.01 | ||
| M1 | 22 | 17 | 5 | 6.61 | ||
| NA | 0 | |||||
| Clinical stage | 0.051 | 0.022 | ||||
| 0+I+II | 11 | 5 | 6 | 10.15 | ||
| III+IV | 45 | 36 | 9 | 7.44 | ||
| NA | 4 | 2 | 2 | |||
| Differentiation | 0.284 | 0.057 | ||||
| High+moderate | 12 | 6 | 6 | 10.18 | ||
| Low | 32 | 23 | 9 | 7.73 | ||
| NA | 16 | 14 | 2 | |||